AVDL
USDAvadel Pharmaceuticals plc Ordinary Share
$9.890-0.390 (-3.794%)
Real-time Price
Healthcare
Drug Manufacturers - Specialty & Generic
Ireland
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$10.280
High
$10.350
Low
$9.830
Volume
1.71M
Company Fundamentals
Market Cap
956.7M
Industry
Drug Manufacturers - Specialty & Generic
Country
Ireland
Trading Stats
Avg Volume
1.14M
Exchange
NGM
Currency
USD
52-Week Range
Low $6.38Current $9.890High $17.3
Related News
GlobeNewswire
Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia
DUBLIN, June 05, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that LUMRYZTM has been granted
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.